Results 171 to 180 of about 180,384 (297)

Evaluation of Three Sample Preparation Methods for LC-HRMS Suspect Screening of Contaminants of Emerging Concern in Effluent Wastewater. [PDF]

Anal Chem
Orlando-Véliz D, Bonansea RI, García-Vara M, Nikolopoulou V, López de Alda M.   +4 more
europepmc   +1 more source

Efficient workflow for suspect screening analysis to characterize novel and legacy per- and polyfluoroalkyl substances (PFAS) in biosolids. [PDF]

Anal Bioanal Chem, 2022
Dickman RA, Aga DS.
europepmc   +1 more source

Development and application of a novel accurate mass base suspect screening methodology for the analysis of pharmaceutical residues in surface water by time-of-flight mass spectrometry [PDF]

, 2013
Demeestere, Kristof, Joos, Pieter, Van Langenhove, Herman, Vergeynst, Leendert   +3 more
core  

How to Screen and Manage Suspected Laminopathy

Internal Medicine
Kataoka, Naoya, Sugiyama, Taisei, Imamura, Teruhiko   +2 more
openaire   +2 more sources

Interrogating the immune landscape of microsatellite stable RAS‐mutated colon cancer

Molecular Oncology, EarlyView.
COLOSSUS project RAS‐mutated MSS colon cancer study explored transcriptomics and immune cell density by immunohistochemistry (IHC), Immunoscore (IS), ISIC/TuLIS scores, mutation counts, and detected different prevalences but similar microenvironment composition across immune markers with clinical relevance for future immunotherapy combination ...
Rodrigo Dienstmann, Eduardo García‐Galea, Alice O'Farrell, Zak Kinsella, Maxime Meylan, Florent Petitprez, Ingrid Arijs, Tom Venken, Hari Ps, Adrian Lärkeryd, Ian Miller, Janick Selves, Nadja Meindl‐Beinker, Fiorella Ruiz‐Pace, Elena Élez, Raquel Comas‐Navarro, Frank Lincoln, Dirk Fey, Gift Nyamundanda, Aoife Nolan, Joern Lewin, Raquel Perez‐Lopez, Jonathan Briody, Kathleen Bennett, Walter Kolch, David Matallanas, Alexander Kel, Enrique Arenas, Joaquín Arribas, Bart Ghesquière, Josep Tabernero, Julie Meilleroux, Deborah McNamara, Ray McDermott, Marvin Lim, Mary O'Reilly, Brian Bird, Lisa Stack, Lucia Moloney, Patrick Morris, Keith Egan, Maciej Milewski, Lars Scheuer, Joachim Behringer, Georg Bolz, Ramon Salazar, Cristina Santos, Andrea Ruiz, Orla Casey, Verena Murphy, Matthias Ebert, Livio Trusolino, Diether Lambrechts, Anguraj Sadanandam, Catherine Sautès‐Fridman, Jochen Prehn, Paolo Nuciforo, Jacques Fieschi, Florence Monville, Darran O'Connor, Wolf Fridman, Annette Byrne   +61 more
wiley   +1 more source

Nontarget and Suspect Screening of Fluorinated Ionic Liquids and PFAS in European Wastewaters Using Supercritical Fluid Chromatography. [PDF]

Environ Sci Technol
Tisler S, Zweigle J, Gotil MK, Finckh S, Brack W, Braxmaier EM, Meyer C, Hollender J, Kosjek T, Schymanski EL, Larsson P, Kärrman A, Selin E, Elabbadi D, Elliss H, Kasprzyk-Hordern B, Boogaerts T, Covaci A, Oberacher H, Flores Quintana H, Lai FY, Ahrens L, Assoumani A, Béen F, Christensen JH.   +24 more
europepmc   +1 more source

Screening, searching and confiscation : advice for principals and staff of further education colleges, sixth form colleges and 16-19 academies [PDF]

, 2012

core  

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

Molecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla, Christopher Dirks, Caroline Eiden, Sonja K. Fesenmayer, Femke M. Hormann, Yolande Klootsema, Ingrid Lilienthal, Si Min Zhang, Nikolas Herold, Sean G. Rudd   +9 more
wiley   +1 more source

Reference library for suspect screening of environmental toxicants using ion mobility spectrometry-mass spectrometry. [PDF]

Commun Chem
Teri D, Aly NA, Dodds JN, Zhang J, Thiessen PA, Bolton EE, Joseph KM, Williams AJ, Schymanski EL, Rusyn I, Baker ES.   +10 more
europepmc   +1 more source

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch, Isabel Vogel, Sina Nokodian, Johanna Moeller, Antonia Blechschmidt, Vicky Hecht, Vanessa Kuentzel, Katharina Thiedig, Melissa Schwab, Oliver Schilling, Holger Bronger, Marion Kiechle, Viktor Magdolen, Tobias Dreyer   +13 more
wiley   +1 more source